FDA approves Vertex's non-opioid painkiller, first new kind of pain medicine in decades

1. FDA approved Vertex's non-opioid painkiller, a historic milestone. 2. Potential for over $1 billion in annual sales after FDA approval. 3. The drug effectively reduces pain intensity and shows fewer side effects. 4. Vertex aims for chronic pain approval, targeting a larger market. 5. Around 80 million patients seek treatment for moderate-to-severe pain annually.